Jubilant Organosys Ltd said on Tuesday that it has entered into a five-year agreement with US-based pharmaceutical company, Eli Lily.
HT Image
Under the agreement, Jubilant along with its subsidiaries --- Jubilant Biosys Ltd and Jubilant Chemsys Ltd (Jubilant), will provide a range of collaboration drug discovery services to Lilly, the company informed the Bombay Stock Exchange.